DÄ internationalArchive16/2019Invasive fungal infection

Review article

Invasive fungal infection

New treatments to meet new challenges

Dtsch Arztebl Int 2019; 116(16): 271-8; DOI: 10.3238/arztebl.2019.0271

von Lilienfeld-Toal, M; Wagener, J; Einsele, H; Cornely, O A; Kurzai, O

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Nationales Referenzzentrum für Invasive Pilzinfektionen Leibniz,
Institut für Naturstoff-Forschung und Infektionsbiologie, Hans-Knöll-Institut, Jena: Prof. Dr. med. Marie von Lilienfeld-Toal,
PD Dr. med. Johannes Wagener, Prof. Dr. med. Oliver Kurzai
Universitätsklinikum Jena, Klinik für Innere Medizin II:
Prof. Dr. med. Marie von Lilienfeld-Toal
Universität Würzburg, Institut für Hygiene und Mikrobiologie,
Lehrstuhl für Medizinische Mikrobiologie und Mykologie, Würzburg:
PD Dr. med. Johannes Wagener, Prof. Dr. med. Oliver Kurzai
Universitätsklinikum Würzburg, Klinik und Poliklinik für Innere Medizin II: Prof. Dr. med. Hermann Einsele
InfectControl 2020, Jena/Würzburg:
Prof. Dr. med. Hermann Einsele, Prof. Dr. med. Oliver Kurzai
Cologne Excellence Cluster on Cellular Stress Responses
in Aging-Associated Diseases (CECAD), Klinik I für Innere Medizin,
European Excellence Center for Medical Mycology (ECMM),
Deutsches Zentrum für Infektionsforschung (DZIF)
Partner Site Bonn Köln, Universität zu Köln:
Prof. Dr. med. Oliver A. Cornely
1.Fisher MC, Henk DA, Briggs CJ, et al.: Emerging fungal threats to animal, plant and ecosystem health. Nature 2012; 484: 186–94 CrossRef MEDLINE PubMed Central
2.Ruhnke M, Groll AH, Mayser P, et al.: Estimated burden of fungal infections in Germany. Mycoses 2015; 58 (Suppl 5): 22–8. CrossRefMEDLINE
3.Bitar D, Lortholary O, Le Strat Y, et al.: Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 2014; 20: 1149–55 CrossRef MEDLINE PubMed Central
4.Meyer E, Geffers C, Gastmeier P, Schwab F: No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011. Euro Surveill 2013; 18: pii: 20505.
5.Dignani MC: Epidemiology of invasive fungal diseases on the basis of autopsy reports. F1000Prime Rep 2014; 6: 81 CrossRef MEDLINE PubMed Central
6.Winters B, Custer J, Galvagno SM, Jr., et al.: Diagnostic errors in the intensive care unit: a systematic review of autopsy studies. BMJ Qual Saf 2012; 21: 894–902 CrossRef MEDLINE
7.Walther G, Stasch S, Kaerger K, et al.: Fusarium Keratitis in Germany. J Clin Microbiol 2017; 55: 2983–95 CrossRef MEDLINE PubMed Central
8.Wagener J, Walther G, Kurzai O: Antimykotikaresistenz bei klinisch relevanten Erregern invasiver Pilzinfektionen in Deutschland. Der Mikrobiologe 2018; 28: 13–8.
9.Steinmann J, Hamprecht A, Vehreschild MJ, et al.: Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother 2015; 70: 1522–6 CrossRef MEDLINE
10.Chowdhary A, Meis JF, Guarro J, et al.: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 2014; 20 (Suppl 3): 47–75 CrossRef MEDLINE
11.Cornely OA, Arikan-Akdagli S, Dannaoui E, et al.: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014; 20 (Suppl 3): 5–26 CrossRef MEDLINE
12.Cornely OA, Bassetti M, Calandra T, et al.: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 (Suppl 7): 19–37 CrossRef MEDLINE
13.Hope WW, Castagnola E, Groll AH, et al.: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 2012; 18 (Suppl 7): 38–52 CrossRefMEDLINE
14.Lortholary O, Petrikkos G, Akova M, et al.: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect 2012; 18 (Suppl 7): 68–77 CrossRef MEDLINE
15.Tortorano AM, Richardson M, Roilides E, et al.: ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 2014; 20 (Suppl 3): 27–46 CrossRef MEDLINE
16.Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al.: Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 2018; 24 (Suppl 1): e1–e38 CrossRef MEDLINE
17.Ullmann AJ, Akova M, Herbrecht R, et al.: ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 2012; 18 (Suppl 7): 53–67 CrossRef MEDLINE
18.De Pauw B, Walsh TJ, Donnelly JP, et al.: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–21 CrossRef MEDLINE PubMed Central
19.Schauwvlieghe A, Rijnders BJA, Philips N, et al.: Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018; 6: 782–92 CrossRef
20.Mohedano Del Pozo RB, Rubio Alonso M, Cuetara Garcia MS: Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease. Rev Iberoam Micol 2018; 35: 117–22 CrossRef MEDLINE
21.Meersseman W, Lagrou K, Spriet I, et al.: Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35: 1526–31 CrossRef MEDLINE
22.Leeflang MM, Debets-Ossenkopp YJ, Wang J, et al.: Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2015: CD007394 CrossRef
23.Barnes RA, White PL, Morton CO, et al.: Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips. Medical Mycol 2018; 56: 60–72 CrossRef MEDLINE
24.Boch T, Reinwald M, Spiess B, et al.: Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1–3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study. J Crit Care 2018; 47: 198–203 CrossRef MEDLINE
25.Heng SC, Chen SC, Morrissey CO, et al.: Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Diagn Microbiol Infect Dis 2014; 79: 322–7 CrossRef MEDLINE
26.Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE: Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos Trans R Soc Lond B Biol Sci 2016; 371: pii: 20150460 CrossRef MEDLINE PubMed Central
27.Mellinghoff SC, Panse J, Alakel N, et al.: Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol 2018; 97: 197–207 CrossRef MEDLINE PubMed Central
28.Pappas PG, Kauffman CA, Andes DR, et al.: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62: e1–e50 CrossRef
29.Ruhnke M, Rickerts V, Cornely OA, et al.: Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 2011; 54: 279–310 CrossRef MEDLINE
30.Reboli AC, Rotstein C, Pappas PG, et al.: Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007; 356: 2472–82 CrossRef MEDLINE
31.Patterson TF, Thompson GR 3rd, Denning DW, et al.: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 63: e1– e 60.
32.Mousset S, Buchheidt D, Heinz W, et al.: Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2014; 93: 13–32 CrossRef MEDLINE PubMed Central
33.Herbrecht R, Denning DW, Patterson TF, et al.: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–15 CrossRef MEDLINE
34.Maertens JA, Raad, II, Marr KA, et al.: Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet 2016; 387: 760–9 CrossRef
35.Vehreschild JJ, Heussel CP, Groll AH, et al.: Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis. Eur Radiol 2017; 27: 3275–82 CrossRef MEDLINE
36.FlorCruz NV, Evans JR: Medical interventions for fungal keratitis. Cochrane Database Syst Rev 2015; 4: CD004241.
37.McCarthy MW, Kontoyiannis DP, Cornely OA, Perfect JR, Walsh TJ: Novel agents and drug targets to meet the challenges of resistant fungi. J Infect Dis 2017; 216: S474–S83 CrossRef MEDLINE
38.Kullberg BJ, Arendrup MC: Invasive Candidiasis. N Engl J Med 2015; 373: 1445–56 CrossRef MEDLINE
39.Cunha C, Aversa F, Lacerda JF, et al.: Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med 2014; 370: 421–32 CrossRef MEDLINE
40.Geissel B, Loiko V, Klugherz I, et al.: Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus. Nat Commun 2018; 9: 3098 CrossRef MEDLINE PubMed Central
e1.Frick WF, Pollock JF, Hicks AC, et al.: An emerging disease causes regional population collapse of a common North American bat species. Science 2010; 329: 679–82 CrossRef MEDLINE
e2.Crawford AJ, Lips KR, Bermingham E: Epidemic disease decimates amphibian abundance, species diversity, and evolutionary history in the highlands of central Panama. Proc Natl Acad Sci USA 2010; 107: 13777–82 CrossRef MEDLINE PubMed Central
e3.Dean R, Van Kan JA, Pretorius ZA, et al.: The Top 10 fungal pathogens in molecular plant pathology. Mol Plant Pathol 2012; 13: 414–30 CrossRef CrossRef MEDLINE
e4.Duggan S, Leonhardt I, Hünniger K, Kurzai O: Host response to Candida albicans bloodstream infection and sepsis. Virulence 2015; 6: 316–26 MEDLINE PubMed Central
e5.Rajasingham R, Smith RM, Park BJ, et al.: Global burden of disease of
HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 2017; 17: 873–81 CrossRef
e6.Arendrup MC, Perlin DS: Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 2014; 27: 484–92 CrossRef MEDLINE PubMed Central
e7.Jeffery-Smith A, Taori SK, Schelenz S, et al.: Candida auris: a Review of the Literature. Clin Microbiol Rev 2017; 31: pii: e00029–17.
e8.Friedrich R, Rappold E, Bogdan C, Held J: Comparative analysis of the wako beta-glucan test and the fungitell assay for diagnosis of candidemia and pneumocystis jirovecii pneumonia. J Clin Microbiol 2018; 56: pii: e00464–18 MEDLINE PubMed Central
e9.Held J, Kohlberger I, Rappold E, Busse Grawitz A, Hacker G: Comparison of (1->3)-beta-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013; 51: 1158–64 CrossRef MEDLINE PubMed Central
e10.Dichtl K, Seybold U, Wagener J: Serological biomarkers of candidemia: a retrospective evaluation of three assays. Infection 2018: doi: 10.1007/s15010–018–1224–3. [Epub ahead of print] CrossRef
e11.Alexander BD, Johnson MD, Pfeiffer CD, et al.: Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 2013; 56: 1724–32 CrossRef MEDLINE PubMed Central
e12.Seufert R, Sedlacek L, Kahl B, et al.: Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany. J Antimicrob Chemother 2018; 73: 2047–53 CrossRef MEDLINE
e13.Kullberg BJ, Blijlevens NMA, Janssen JJWM, et al.: Stichting Werkgroep Antibioticabeleid. https://www.swab.nl/swab/cms3.nsf/uploads/3AA7A56CE879587BC12581F80061297F/$FILE/SWAB%20Richtlijn%20Mycosen%202017%20(final).pdf (last accessed on 19. March 2019).
e14.Tissot F, Agrawal S, Pagano L, et al.: ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica 2017; 102: 433–44 CrossRef MEDLINE PubMed Central
e15.Schwartz S, Ruhnke M, Ribaud P, et al.: Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005; 106: 2641–5 CrossRef MEDLINE
e16.Marr KA, Schlamm HT, Herbrecht R, et al.: Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med 2015; 162: 81–9 CrossRef MEDLINE
e17.Elgamal EA, Murshid WR: Intracavitary administration of amphotericin B in the treatment of cerebral aspergillosis in a non immune-compromised patient: case report and review of the literature. Br J Neurosurg 2000; 14: 137–41 CrossRef
e18.Kovanda LL, Kolamunnage-Dona R, Neely M, Maertens J, Lee M, Hope WW: Pharmacodynamics of isavuconazole for invasive mold disease: role of galactomannan for real-time monitoring of therapeutic response. Clin Infect Dis 2017; 64: 1557–63 CrossRef MEDLINE PubMed Central
e19.Behrens-Baumann W, Finis D, MacKenzie C, Roth M, Geerling G: [Keratomycosis—therapy standards and new developments]. Klin Monbl Augenheilkd 2015; 232: 754–64 MEDLINE
e20.Prajna NV, Krishnan T, Rajaraman R, et al.: Adjunctive oral voriconazole treatment of fusarium keratitis: a secondary analysis from the Mycotic Ulcer Treatment Trial II. JAMA Ophthalmol 2017; 135: 520–5 CrossRef CrossRef MEDLINE PubMed Central
e21.Prajna NV, Krishnan T, Rajaraman R, et al.: Effect of oral voriconazole on fungal keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): a randomized clinical trial. JAMA Ophthalmol 2016; 134: 1365–72 CrossRef MEDLINE PubMed Central
e22.Passweg JR, Baldomero H, Bader P, et al.: Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2018; 53: 1139–48 CrossRef MEDLINE PubMed Central
e23.Passweg JR, Baldomero H, Bader P, et al.: Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016; 51: 786–92 CrossRef MEDLINE PubMed Central
e24.McCarthy MW, Walsh TJ: Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert Rev Anti Infect Ther 2017; 15: 577–84 CrossRef MEDLINE
e25.Anesi JA, Baddley JW: Approach to the solid organ transplant patient with suspected fungal infection. Infect Dis Clin North Am 2016; 30: 277–96 CrossRef MEDLINE PubMed Central
e26.Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N: Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66 (Suppl 1): i5–14 CrossRef MEDLINE
e27.Clark NM, Weigt SS, Fishbein MC, Kubak B, Belperio JA, Lynch JP, 3rd: Fungal infections complicating lung transplantation. Semin Respir Crit Care Med 2018; 39: 227–54 CrossRef MEDLINE
e28.Caira M, Candoni A, Verga L, et al.: Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study). Haematologica 2015; 100: 284–92 CrossRef MEDLINE PubMed Central
e29.Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–8 CrossRef
e30.Maskarinec SA, Johnson MD, Perfect JR: Genetic susceptibility to fungal infections: What is in the Genes? Curr Clin Microbiol Rep 2016; 3: 81–91 CrossRef MEDLINE PubMed Central
e31.Kumar V, Cheng SC, Johnson MD, et al.: Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia. Nat Commun 2014; 5: 4675 CrossRef MEDLINE PubMed Central
e32.Warris A: Immunopathology of aspergillus infections in children with chronic granulomatous disease and cystic fibrosis. Pediatr Infect Dis J 2018: doi: 10.1097/INF.0000000000002265. [Epub ahead of print] CrossRef
e33.Cunha C, Goncalves SM, Duarte-Oliveira C, et al.: IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. J Allergy Clin Immunol 2017; 140: 867–70.e9.
e34.Lemarie E, Lemaire B, Saudeau D, Lavandier M, Renoux M, Renoux G: Disseminated aspergillosis in a patient with bronchiectasis. A 15-month clinical and immunological follow-up. Respiration 1986; 49: 235–40 MEDLINE
e35.Pegues DA, Lasker BA, McNeil MM, Hamm PM, Lundal JL, Kubak BM: Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin Infect Dis 2002; 34: 412–6 CrossRef MEDLINE
e36.Oken MM, Creech RH, Tormey DC, et al.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–55 CrossRef MEDLINE
e37.Anderson TM, Clay MC, Cioffi AG, et al.: Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol 2014; 10: 400–6 CrossRef MEDLINE PubMed Central
e38.Clancy CJ, Pappas PG, Vazquez J, et al.: Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida Panel. Clin Infect Dis 2018; 66: 1678–86 CrossRef MEDLINE
e39.Brasnu E, Bourcier T, Dupas B, et al.: In vivo confocal microscopy in fungal keratitis. Br J Ophthalmol 2007; 91: 588–91 CrossRef MEDLINE PubMed Central
e40.Labbe A, Khammari C, Dupas B, et al.: Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis. Ocul Surf 2009; 7: 41–52 CrossRef